Publications by authors named "MinShan Chen"

Claim this Profile
S
Spatial single-cell proteomics landscape decodes the tumor microenvironmental ecosystem of intrahepatic cholangiocarcinoma.
Libing Hong, Jie Mei, Xuqi Sun, Yifan Wu, Zhen Dong, Jinlin Cheng, Minshan Chen

Hepatology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition).
Jian Zhou, Huichuan Sun, Zheng Wang, Wenming Cong, Mengsu Zeng, Min Chen, Weixia Chen, Yajin Chen, Yongjun Chen, Wenwu Cheng, Shuqun Cheng, Xiangcheng Li, Hongcheng Shi, Minshan Chen

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.
Zefeng Du, Zhicheng Lai, Yexing Huang, Hailong Chen, Ping Ma, Minshan Chen

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant medication use and clinical outcome in hepatocellular carcinoma treated with immune-based therapy: a multicenter analysis.
Jun-Zhe Yi, Jie Xu, Jiang-Zheng Zeng, Yu-Jia Song, Yu-Nan Zhang, Cheng-Mou Huang, Min-Shan Chen

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis.
Liuyan Ding, Hui Shu, Minshan Chen, Fengchu Liang, Tingting Gan

NPJ Parkinsons Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposing re-classification of bile duct cancer and intrahepatic cholangiocarcinoma: A suggested modification based on the WHO classification.
Yangxun Pan, Dandan Hu, Teng Long, Minshan Chen

Eur J Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xg-13, a derivate of marine natural product, exhibits anti-angiogenesis ability in hepatocellular carcinoma via inhibiting Axl signaling pathway.
Minshan Chen, Runyu Liu, Yueming He, Junyan Li, Fuqin Yang, Minfeng Chen

Biochem Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhapontigenin attenuates neurodegeneration in a parkinson's disease model by downregulating mtDNA-cGAS-STING-NF-κB-mediated neuroinflammation via PINK1/DRP1-dependent microglial mitophagy.
Zhongqiang Su, Hui Shu, Xingting Huang, Liuyan Ding, Fengchu Liang, Minshan Chen

Cell Mol Life Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A possible mechanism of facial contour and extremity deformity in paediatric patients with linear scleroderma.
Guang-Ming Han, Yi-Fei Xu, Xi-Wen Zheng, Xiao-Yi Zhang, Zhao-Xia Li, Min-Shan Chen

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A/IL-17RA pathway.
Fengchu Liang, Zongtang Xu, Liuyan Ding, Ziting Zhu, Minshan Chen

J Hazard Mater· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Transarterial Chemoembolization plus Ablation versus Surgical Resection in Patients with Large BCLC Stage A/B HCC.
Ying-Wen Hou, Tian-Qi Zhang, Li-Di Ma, Yi-Quan Jiang, Xue Han, Min-Shan Chen

Acad Radiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.
Suixing Zhong, Junzhe Yi, Song Chen, Xiaoyan Mo, Qifeng Chen, Minshan Chen

Hepatol Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021.
Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Xiaoming Chen, Minshan Chen, Yajin Chen, Xiangchen Li, Yongjun Chen

Cancer Innov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and validation of a risk stratification system for assessing axillary status after neoadjuvant therapy in node-positive breast cancer: a multicenter, prospective, observational study.
Jia-Xin Huang, Jing-Si Mei, Fei Chen, Jia-Hui Huang, Yu-Ting Tan, Min-Shan Chen

Int J Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin for resectable single large hepatocellular carcinoma.
Zili Hu, Min Deng, Yizhen Fu, Zhongguo Zhou, Huanwei Chen, Minshan Chen

Int J Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Lichang Huang, Yujie Xu, Na Liu, Hailong Chen, Zichao Wu, Minshan Chen, Zhicheng Lai

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).
Yu Yang, Juxian Sun, Jianqiang Cai, Minshan Chen, Chaoliu Dai, Gang Chen, Juan Chen, Ping Chen, Yongshun Chen, Shu-Qun Cheng

Liver Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NR4A2 attenuates early brain injury after intracerebral hemorrhage by promoting M2 microglial polarization via TLR4/TRAF6/NF-κB pathway inhibition.
Di Hu, Cheng Huang, Ling Tang, Jiawen Lei, Jiaqi Wang, Minshan Chen

Cell Mol Life Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD.
Teng Long, Zhenyun Yang, Weijie Wu, Minshan Chen, Dandan Hu

ILIVER· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
Yizhen Fu, Yaojun Zhang, Dandan Hu, Zhongguo Zhou, Li Xu, Minshan Chen

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update.
Xinyu Bi, Haitao Zhao, Hong Zhao, Guangming Li, Xiaodong Wang, Bo Chen, Minshan Chen, Shuqun Cheng

Liver Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014-2023.
Qi-Feng Chen, Xiong-Ying Jiang, Min-Shan Chen, Ning Lyu, Ming Zhao

Ann Surg Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
Yao-Jun Zhang, Jinbin Chen, Zhongguo Zhou, Dandan Hu, Juncheng Wang, Min-Shan Chen

Radiology· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment.
Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Juncheng Wang, Jinbin Chen, Minshan Chen

Mol Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gd-EOB-DTPA-enhanced MRI proves advantageous in selecting surgical candidates for patients with early-stage hepatocellular carcinoma: An analysis in terms of oncological outcomes.
Zhiwei Ye, Jing Zhao, Dandan Hu, Zhoutian Yang, Jinbin Chen, Minshan Chen

ILIVER· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis